Abstract Background Vaccination against Human Papillomavirus (HPV) is recommended for
adolescent young women prior to sexual debut to reduce cervical cancer related mortality …

Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many
countries for the prevention of cervical cancer, the second most important cause of cancer …

Background Cervical and oropharyngeal cancers are associated with human papillomavirus
(HPV) infection, which can be prevented with the vaccines. However, uptake of the HPV …

Background Human papillomavirus (HPV) is a necessary cause of cervical dysplasia and
cancer, and of genital warts. Few studies have examined attitudes to HPV vaccination since …

Objective The objective of this study was to provide a systematic review of peer-reviewed
literature on the factors associated with HPV vaccine acceptability among adults in African …

Abstract Background Human Papilloma Virus (HPV) is the most common sexually
transmitted infection worldwide. Globally, both men and women have a 50% risk of being …

We currently have the knowledge and experience to prevent much of human papillomavirus
(HPV)-related disease burden globally. In many countries where prophylactic HPV …

Background The human papillomavirus (HPV) vaccine offers an opportunity to reduce health
inequalities associated with cervical cancer provided the vaccine is delivered equitably at …

OBJECTIVE: To assess human papillomavirus (HPV) vaccination coverage after
demonstration projects conducted in India, Peru, Uganda and Viet Nam by PATH and …

Background Human papillomavirus (HPV) vaccination targets high-risk HPV16/18 that
cause 70% of all cancers of the cervix. In Australia there is a fully-funded, school-based …